IP Library Patent Application 16535992
Patent Application
App. No. 16/535,992

METHOD FOR THE SITE-SPECIFIC ENZYMATIC LABELLING OF NUCLEIC ACIDS IN VITRO BY INCORPORATION OF UNNATURAL NUCLEOTIDES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/535,992
Abstract

Provided herein are analogs of unnatural nucleotides bearing predominantly hydrophobic nucleobase analogs that form unnatural base pairs during DNA polymerase-mediated replication of DNA or RNA polymerase-mediated transcription of RNA. In this manner, the unnatural nucleobases can be introduced in a site-specific way into oligonucleotides (single or double stranded DNA or RNA), where they can provide for site-specific cleavage, or can provide a reactive linker than can undergo functionalization with a cargo-bearing reagent by means of reaction with a primary amino group or by means of click chemistry with an alkyne group of the unnatural nucleobase linker.

Claims (42)

1 . A double-stranded oligonucleotide comprising a first strand and a second strand, wherein:

(a) the first strand comprises a first compound of the formula

wherein R 2 is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, methoxy, methanethiol, methaneseleno, halogen, cyano, and azido; and

(b) the second strand comprises a second compound selected from the group consisting of

and wherein in the case of each of (a) and (b), the wavy line indicates a bond to a 2′-deoxyribosyl moiety.

2 . The double-stranded oligonucleotide of claim 1 , wherein the first compound and the second compound form a base pair in the double-stranded oligonucleotide.

3 . The double-stranded oligonucleotide of claim 2 , wherein the R 2 is hydrogen or halogen.

4 . The double-stranded oligonucleotide of claim 3 , wherein the R 2 is hydrogen.

5 . The double-stranded oligonucleotide of claim 3 , wherein the R 2 is halogen.

6 . The double-stranded oligonucleotide of claim 5 , wherein the halogen is a fluoro.

7 . The double-stranded oligonucleotide of claim 4 , wherein the second compound is selected from the group consisting of

8 . The double-stranded oligonucleotide of claim 7 , wherein the second compound is selected from the group consisting of

9 . The double-stranded oligonucleotide of claim 8 , wherein the second compound is selected from the group consisting of

10 . The double-stranded oligonucleotide of claim 9 , wherein the second compound is selected from the group consisting of

11 . The double-stranded oligonucleotide of claim 10 , wherein the second compound is

12 . The double-stranded oligonucleotide of claim 10 , wherein the second compound is

13 . A composition comprising:

(a) a 2′-deoxyribonucleic acid (DNA) molecule comprising a first compound of the formula

wherein R 2 is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, methoxy, methanethiol, methaneseleno, halogen, cyano, and azido, and wherein the wavy line indicates a bond to a 2′-deoxyribosyl moiety; and

(b) a ribonucleic acid (RNA) molecule comprising a second compound selected from the group consisting of

wherein the wavy line indicates a bond to a ribosyl moiety.

14 . The composition of claim 13 , wherein the first compound and the second compound form a base pair.

15 . The composition of claim 14 , wherein the R 2 is hydrogen or halogen.

16 . The composition of claim 15 , wherein the R 2 is hydrogen.

17 . The composition of claim 16 , wherein the second compound is selected from the group consisting of

18 . The composition of claim 17 , wherein the second compound is selected from the group consisting of

19 . The composition of claim 18 , wherein the second compound is selected from the group consisting of

20 . The composition of claim 19 , wherein the second compound is selected from the group consisting of

21 . The composition of claim 20 , wherein the second compound is

22 . The composition of claim 21 , wherein the second compound is

23 . A composition comprising:

(a) a first ribonucleic acid (RNA) molecule comprising a first compound of the formula

wherein R 2 is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, methoxy, methanethiol, methaneseleno, halogen, cyano, and azido; and

(b) a second ribonucleic acid (RNA) molecule comprising a second compound selected from the group consisting of

and wherein in the case of each of (a) and (b), the wavy line indicates a bond to a ribosyl moiety.

24 . The composition of claim 23 , wherein the first compound and the second compound form a base pair.

25 . The composition of claim 24 , wherein the R 2 is hydrogen.

26 . The composition of claim 25 , wherein the second compound is selected from the group consisting of

27 . The composition of claim 26 , wherein the second compound is selected from the group consisting of

28 . The composition of claim 27 , wherein the second compound is selected from the group consisting of

29 . The composition of claim 28 , wherein the second compound is

30 . The composition of claim 28 , wherein the second compound is

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2019
From: ROMESBERG, FLOYD E.; MALYSHEV, DENIS A.; LIN, LINGJUN; LAVERGNE, THOMAS; LI, ZHENGTAO
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 050269/0279 →